Goldman Sachs economists released an analysis that projected that President-elect Trump's tax cuts and deregulation will ...
Gold advanced after posting its biggest weekly drop since 2021 as traders weighed the outlook for Federal Reserve rate cuts, ...
Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $137.00. The company’s shares closed last Friday at $99.72.
Goldman Sachs Research predicts a strong year for global economic growth in 2025, forecasting a 2.7% increase in global GDP ...
The past year’s rally has left little room for U.S. stocks to increase in value any further — meaning investors should start ...
The Wall Street giant set out to build a marketing 'army' under its first CMO. Some high-level insiders question whether it's ...
O ouro vai subir para um recorde no próximo ano devido às compras de bancos centrais e cortes nas taxas de juros nos EUA, de ...